Quadrant Capital Group LLC Purchases 6,519 Shares of Danaher Corporation $DHR

Quadrant Capital Group LLC boosted its position in shares of Danaher Corporation (NYSE:DHR) by 50.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 19,401 shares of the conglomerate’s stock after purchasing an additional 6,519 shares during the period. Quadrant Capital Group LLC’s holdings in Danaher were worth $3,847,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in DHR. WFA of San Diego LLC bought a new stake in Danaher in the second quarter worth about $26,000. ANTIPODES PARTNERS Ltd bought a new position in shares of Danaher during the third quarter valued at approximately $27,000. Howard Hughes Medical Institute purchased a new stake in shares of Danaher in the second quarter worth approximately $27,000. TruNorth Capital Management LLC purchased a new stake in shares of Danaher in the third quarter worth approximately $28,000. Finally, Tripletail Wealth Management LLC bought a new stake in shares of Danaher during the 3rd quarter worth approximately $31,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the sale, the executive vice president directly owned 5,099 shares of the company’s stock, valued at $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 11.20% of the stock is currently owned by company insiders.

Danaher Trading Down 1.8%

DHR opened at $195.32 on Wednesday. The stock’s fifty day moving average is $221.18 and its two-hundred day moving average is $215.83. The company has a market capitalization of $138.12 billion, a P/E ratio of 38.75, a PEG ratio of 2.69 and a beta of 0.93. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $242.80. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, topping the consensus estimate of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The business had revenue of $6.84 billion during the quarter, compared to analysts’ expectations of $6.79 billion. During the same period in the prior year, the business earned $2.14 EPS. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. Analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be issued a $0.40 dividend. The ex-dividend date is Friday, March 27th. This is an increase from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. Danaher’s dividend payout ratio is presently 25.40%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. Wells Fargo & Company boosted their price objective on Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a report on Monday, December 15th. TD Cowen reiterated a “buy” rating on shares of Danaher in a research report on Wednesday, January 7th. Morgan Stanley initiated coverage on shares of Danaher in a research note on Monday, December 1st. They set an “overweight” rating and a $270.00 target price for the company. Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a report on Saturday, November 22nd. Finally, KeyCorp reaffirmed an “overweight” rating on shares of Danaher in a research note on Thursday, January 29th. Twenty equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $253.86.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.